Press Releases
Recro Pharma Announces PDUFA Date for IV Meloxicam
Recro Announces Expansion of CDMO Service Capabilities
Recro Pharma to Participate in Upcoming Investor Conferences
Recro Pharma to Present IV Meloxicam Data at PAINWeek® 2018
Recro Pharma Provides Regulatory Update for IV Meloxicam
Recro Pharma Reports Second Quarter 2018 Financial Results
Recro Pharma to Report Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 7, 2018
Recro Pharma Announces Publication of Phase III IV Meloxicam Abdominoplasty Data in Plastic and Reconstructive Surgery Global Open Journal
Recro Pharma Receives Complete Response Letter from the FDA
